The safety of volunteers participating in trials is a priority, the organization emphasizes.
WHO has welcomed the suspension of trials of the AstraZeneca coronavirus vaccine, as the safety of volunteers is a priority. This was announced by the press service of the British-Swedish pharmaceutical company, Reuters reported on Wednesday, September 9.
WHO recommended, вЂњto fully adhere to established testing protocols in all vaccine trials to ensure the safety of volunteers and the safety and efficacy of vaccines.вЂќ
вЂњWe are pleased to see that the vaccine developers ensure the scientific validity of the trials and follow the principles and rules of vaccine development,вЂќ the organization said.
In turn, the head of the British Ministry of Health Matt Hancock said that the British government will allow the massive use of the vaccine only вЂњwhen there is a firm confidence in its safety.вЂќ
вЂњIt doesn't have to [means that the vaccine will be approved later than planned]. It all depends on what conclusions will be drawn after all the circumstances are considered. There was already a pause in vaccine trials this summer, but then the issue was resolved and there were no problems arose, вЂњHancock said.
We will remind that earlier the leader of the race for the vaccine stopped testing after the infection of a volunteer. For the first time, trials of a coronavirus vaccine have been suspended. The reason was the infection with COVID-19 of one of the volunteers who received the drug.